USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α

Although endocrine therapies targeting estrogen receptor α (ERα) are effective in managing ER positive (+) breast cancer, many patients have primary resistance or develop resistance to endocrine therapies. In addition, ER+ breast cancer with PIK3CA activating mutations and 11q13-14 amplification hav...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Cao, Jiawei, Wu, Du, Wu, Guang, Wang, Yaqi, Ren, Tianhao, Wang, Yang, Lv, Yingshuai, Sun, Wei, Wang, Jieyi, Qian, Changrui, He, Licai, Yang, Kaiyan, Li, Hongzhi, Gu, Haihua
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8206120/
https://ncbi.nlm.nih.gov/pubmed/34131114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-021-03904-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados